Radiation and breast reconstruction: Algorithmic approach and evidence-based outcomes

2016 ◽  
Vol 113 (8) ◽  
pp. 906-912 ◽  
Author(s):  
Bassim El-Sabawi ◽  
Joseph N. Carey ◽  
Thomas M. Hagopian ◽  
Hani Sbitany ◽  
Ketan M. Patel
2019 ◽  
Vol 26 (4) ◽  
pp. 711-715
Author(s):  
Lisa J. Ellis ◽  
Harmeet Bhullar ◽  
Kimberley Hughes ◽  
David J. Hunter‐Smith ◽  
Warren M. Rozen

2012 ◽  
Vol 69 (4) ◽  
pp. 446-450 ◽  
Author(s):  
Randall O. Craft ◽  
Branimir Damjanovic ◽  
Amy S. Colwell

2021 ◽  
Vol 6 (2) ◽  
pp. 238146832110420
Author(s):  
Jessica Boateng ◽  
Clara N. Lee ◽  
Randi E. Foraker ◽  
Terence M. Myckatyn ◽  
Kimi Spilo ◽  
...  

Objective. To explore barriers and facilitators to implementing an evidence-based clinical decision support (CDS) tool (BREASTChoice) about post-mastectomy breast reconstruction into routine care. Materials and Methods. A stakeholder advisory group of cancer survivors, clinicians who discuss and/or perform breast reconstruction in women with cancer, and informatics professionals helped design and review the interview guide. Based on the Consolidated Framework for Implementation Research (CFIR), we conducted qualitative semistructured interviews with key stakeholders (patients, clinicians, informatics professionals) to explore intervention, setting characteristics, and process-level variables that can impact implementation. Interviews were transcribed, coded, and analyzed based on the CFIR framework using both inductive and deductive methods. Results. Fifty-seven potential participants were contacted; 49 (85.9%) were eligible, and 35 (71.4%) were enrolled, continuing until thematic saturation was reached. Participants consisted of 13 patients, 13 clinicians, and 9 informatics professionals. Stakeholders thought that BREASTChoice was useful and provided patients with an evidence-based source of information about post-mastectomy breast reconstruction, including their personalized risks. They felt that BREASTChoice could support shared decision making, improve workflow, and possibly save consultation time, but were uncertain about the best time to deliver BREASTChoice to patients. Some worried about cost, data availability, and security of integrating the tool into an electronic health record. Most acknowledged the importance of showing clinical utility to gain institutional buy-in and encourage routine adoption. Discussion and Conclusion. Stakeholders felt that BREASTChoice could support shared decision making, improve workflow, and reduce consultation time. Addressing key questions such as cost, data integration, and timing of delivering BREASTChoice could build institutional buy-in for CDS implementation. Results can guide future CDS implementation studies.


2012 ◽  
Vol 28 (08) ◽  
pp. 515-520 ◽  
Author(s):  
Billur Sezgin ◽  
Suhan Ayhan ◽  
Serhan Tuncer ◽  
Ayse Sencan ◽  
Mubin Aral

Urology ◽  
2016 ◽  
Vol 88 ◽  
pp. 43-48 ◽  
Author(s):  
Aaron M. Potretzke ◽  
B. Alexander Knight ◽  
Theodora A. Potretzke ◽  
Jeffrey A. Larson ◽  
Sam B. Bhayani

2010 ◽  
Vol 125 (5) ◽  
pp. 1318-1327 ◽  
Author(s):  
Alan J. Durkin ◽  
Yvonne N. Pierpont ◽  
Shitel Patel ◽  
M. Lance Tavana ◽  
M. Georgina Uberti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document